Gilead Sciences (GILD) earnings

Earnings (net income) · fiscal 2025
$8.51B

Gilead Sciences (GILD) reported net income of $8.51B in fiscal 2025 (the year ended December 31, 2025). That is 1672.9% higher than the $480.00M of fiscal 2024. Figures as of 18 Nov 2026, 10:50 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Earnings (net income), fiscal 2025
$8.51B
Change on fiscal 2024
+1672.9%
Growth, 5 years
+133.3% a year
Growth, 10 years
−7.3% a year
Highest on record
$18.11Bfiscal 2015
Lowest on record
$123.00Mfiscal 2020
Fiscal years on record
192007–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Gilead Sciences earnings, in more detail

Over the five fiscal years to 2025 net income grew at a compound 133.3% a year; over ten years the rate was −7.3% a year. Across the 19 fiscal years on record (2007–2025), the highest was $18.11B in fiscal 2015 and the lowest $123.00M in fiscal 2020.

History · 19 fiscal years

Earnings (net income) by fiscal year

Gilead Sciences earnings, year by year

Gilead Sciences (GILD) earnings by fiscal year
Fiscal yearEarnings (net income)ChangeYear ended
2025$8.51B 1,672.9% up
2024$480.00M 91.5% down
2023$5.67B 23.4% up
2022$4.59B 26.2% down
2021$6.23B 4,961.0% up
2020$123.00M 97.7% down
2019$5.39B 1.3% down
2018$5.46B 17.9% up
2017$4.63B 65.7% down
2016$13.50B 25.4% down
2015$18.11B 49.6% up
2014$12.10B 293.5% up
2013$3.08B 18.6% up
2012$2.59B 7.5% down
2011$2.80B 3.4% down
2010$2.90B 10.1% up
2009$2.64B 33.2% up
2008$1.98B 24.9% up
2007$1.58B—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement.

How to read it

Compare it across years rather than in isolation — one-off gains and write-downs can swing a single year a long way.

Earnings (net income) at health care companies of similar size

Earnings (net income) of Gilead Sciences and comparable companies
CompanyEarnings (net income)Fiscal year
Thermo Fisher Scientific TMO$6.70B2025
Amgen AMGN$7.71B2025
Gilead Sciences GILD$8.51B2025
Abbott Laboratories ABT$6.52B2025
Novo Nordisk NVODKK 102.43B2025
Pfizer PFE$7.77B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on GILD

Gilead Sciences, figure by figure

Gilead Sciences (GILD) overview: price, valuation and scorecardAll health care companies by market value

Gilead Sciences earnings: questions and answers

What is Gilead Sciences's net income?

Gilead Sciences (GILD) reported net income of $8.51B in fiscal 2025 (the year ended December 31, 2025). That is 1672.9% higher than the $480.00M of fiscal 2024.

What is the growth rate of Gilead Sciences's net income?

Over the five fiscal years to 2025 net income grew at a compound 133.3% a year; over ten years the rate was −7.3% a year.

What are the highest and lowest net income figures on record for Gilead Sciences?

Across the 19 fiscal years on record (2007–2025), the highest was $18.11B in fiscal 2015 and the lowest $123.00M in fiscal 2020.

How is Gilead Sciences's net income calculated?

Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement. For Gilead Sciences it is on record here for 19 fiscal years, 2007 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Gilead Sciences (GILD) earnings”, data as of 18 November 2026. https://funkfolio.com/stock/GILD/earnings

Underlying data: the company's filings with the SEC and Yahoo Finance.